{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:45:54Z","timestamp":1788871554201,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ahj.2013.06.019","type":"journal-article","created":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T03:54:22Z","timestamp":1374810862000},"page":"474-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial"],"prefix":"10.1016","volume":"166","clinical-trial-number":[{"clinical-trial-number":"nct00391872","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Emmanouil S.","family":"Brilakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Cornel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Aylward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Brandrup-Wognsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna R.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Himmelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2013.06.019_bb0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCULATIONAHA.109.877092","article-title":"Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program","volume":"120","author":"Brilakis","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.06.019_bb0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjcard.2008.04.024","article-title":"Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials)","volume":"102","author":"Brilakis","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0015","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2007.12.054","article-title":"Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery","volume":"51","author":"Shah","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.103.3.363","article-title":"Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery","volume":"103","author":"Bhatt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.06.019_bb0025","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0735-1097(96)00344-0","article-title":"Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery","volume":"28","author":"Chen","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcin.2009.06.014","article-title":"Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the stenting of saphenous vein grafts trial","author":"Lichtenwalter","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.ahj.2013.06.019_bb0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2008.11.029","article-title":"A randomized-controlled trial of a paclitaxel-eluting stent vs a similar bare metal stent in saphenous vein graft lesions. The SOS (Stenting Of Saphenous Vein Grafts) Trial","volume":"53","author":"Brilakis","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0040","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0002-9149(97)00171-9","article-title":"Late myocardial ischemic events after saphenous vein graft intervention\u2013importance of initially \u201cnonsignificant\u201d vein graft lesions","volume":"79","author":"Ellis","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0045","first-page":"I396","article-title":"Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft","volume":"114","author":"Mehta","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.06.019_bb0050","first-page":"253","article-title":"Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes","volume":"22","author":"Abdel-Karim","year":"2010","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0055","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.06.019_bb0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ahj.2009.01.003","article-title":"Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"157","author":"James","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.06.019_bb0065","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0002-9149(86)90016-0","article-title":"Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris","volume":"58","author":"Waters","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0070","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0735-1097(88)90447-0","article-title":"Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery","volume":"12","author":"Wiseman","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9149(97)89383-6","article-title":"Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry)","volume":"77","author":"Kleiman","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0080","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0002-9149(00)01125-5","article-title":"Comparison of percutaneous interventions for unstable angina pectoris in patients with and without previous coronary artery bypass grafting","volume":"86","author":"Mathew","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/hc0302.102578","article-title":"Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb\/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial","volume":"105","author":"Labinaz","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.06.019_bb0090","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.amjcard.2003.12.021","article-title":"Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial","volume":"93","author":"Servoss","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00380-008-1114-1","article-title":"Prior coronary artery bypass graft surgery patients undergoing diagnostic coronary angiography have multiple uncontrolled coronary artery disease risk factors and high risk for cardiovascular events","volume":"24","author":"Boatman","year":"2009","journal-title":"Heart Vessels"},{"key":"10.1016\/j.ahj.2013.06.019_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijcard.2006.07.058","article-title":"Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery","volume":"119","author":"Gurfinkel","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","article-title":"Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years","volume":"28","author":"Fitzgibbon","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.06.019_bb0110","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.06.019_bb0115","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.06.019_bb0120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcin.2011.03.018","article-title":"Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients a report from the national cardiovascular data registry","volume":"4","author":"Brilakis","year":"2011","journal-title":"JACC Cardiovasc Interv"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313004328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313004328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:55:45Z","timestamp":1762077345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870313004328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0002870313004328"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2013.06.019","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2013.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}